Navigation Links
Endocare Reports Financial Results for Third Quarter 2008
Date:11/10/2008

Net Revenues Rise, Net Loss Narrows Compared to Prior Year; Operating Loss

Declines 26%

IRVINE, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: ENDO), an innovative medical device company focused on the development of minimally invasive technologies used by urologists and interventional radiologists for tissue and tumor ablation, today reported higher revenue, a 26 percent decline in operating loss, and narrower net loss for the third quarter ended September 30, 2008.

Total revenues for the third quarter of 2008 were $7.6 million, compared to $7.3 million in the third quarter of 2007. Domestic probe sales, as well as the estimated number of domestic cryoablation procedures performed, in the third quarter and the first nine months of 2008 and 2007 are summarized in the following table:

Three Months Ended Nine Months Ended

September 30, September 30,

2008 2007 2008 2007

Estimated domestic cryoablation

procedures 2,263 2,353 7,122 7,104

Number of cryoprobes sold:

Straight probes 8,660 9,957 28,017 29,852

Right-angle probes 2,084 1,564 6,058 4,637

Total 10,744 11,521 34,075 34,489

Probe sales are reported in two categories: straight probes, which are typically, although not always, used in prostate procedures and right-angle probes, which are typically used in procedures other than prostate procedures.

Gross margin in the third quarter
'/>"/>

SOURCE Endocare, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Endocare Reports 2008 First Quarter Financial Results
2. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
3. Isis Reports Financial Results and Highlights for Third Quarter of 2008
4. OncoGenex Reports Third Quarter Financial Results
5. American Oriental Bioengineering Reports Third Quarter 2008 Financial Results
6. AutoImmune Inc. Reports 2008 Third Quarter Financial Results
7. Dendreon Reports Third Quarter 2008 Financial Results
8. Osteotech Reports 2008 Third Quarter Financial Results
9. Halozyme Therapeutics Reports 2008 Third Quarter Financial Results
10. Oncothyreon reports third quarter 2008 financial results
11. InterMune Reports Third Quarter 2008 Financial Results and Business Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... German . , The ... a semiconductor layer. Quantum dots are small structures that spontaneously ... short laser pulse is fired at the photonic crystal, its ... change in the electromagnetic field around it. This change can ... the dot. As soon as the refractive index recovers its ...
(Date:9/30/2014)... Sept. 30, 2014 Pacific Northwest Biotechnology, ... Summary Global Markets Direct,s, ,Pacific Northwest Biotechnology, ... an overview of the Pacific Northwest Biotechnology, LLC,s ... provides comprehensive information on the current therapeutic developmental ... comparative analysis at various stages, therapeutics assessment by ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Over the ... primarily due to rising R&D budgets and increased acceptance ... fast growing pharmaceutical and biotechnology industries are also catalyzing ... laboratory filtration market is expected to grow at a ... is estimated to be worth $2,532.6 million by 2019. ...
(Date:9/30/2014)... 30, 2014 CORD:USE Cord Blood Bank – ... it has entered into an Equity and Exclusive Services ... licensed a series of patented technologies for the isolation of ... applications.  Tianhe is performing Phase I/II clinical trials in ... using Tianhe,s Stem Cell Educator Therapy showing ...
Breaking Biology Technology:Ultrafast remote switching of light emission 2Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 2Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 3Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 2Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 3Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 4Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 5CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 2CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 3CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 4
... Graphene is nature,s thinnest elastic material and displays ... planar geometry, high current-carrying capacity and thermal conductivity ... through ultra-small devices and components for semiconductor circuits ... features is ripples, similar to those seen on ...
... , PRINCETON, N.J., July 24 ... from around the world who gather at InformexUSA 2010 will experience ... allowing them to connect more precisely with others in their specific ... show opens February 16, 2010 in San Francisco, with a new ...
... BOTHELL, WA and VANCOUVER, July 24 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, ... has completed its registered direct offering, previously announced on July ... institutional investors at a price of $20.00 per share, for ... $20 offering price represented a 3.5% discount to the closing ...
Cached Biology Technology:UCR scientists manipulate ripples in graphene, enabling strain-based graphene electronics 2UCR scientists manipulate ripples in graphene, enabling strain-based graphene electronics 3Informex Rebrands Into Separate Pharmaceutical and Specialty Chemical Segments to Better Serve Exhibitors and Attendees 2Informex Rebrands Into Separate Pharmaceutical and Specialty Chemical Segments to Better Serve Exhibitors and Attendees 3OncoGenex Pharmaceuticals Completes $9.5 Million Registered Direct Offering 2OncoGenex Pharmaceuticals Completes $9.5 Million Registered Direct Offering 3
(Date:10/1/2014)... microbes that thrive in the deserts, rainforests, prairies and ... beneath New York City,s Central Park, according to a ... the University of Colorado Boulder. , The research ... Park,s 843 acres and discovered a stunning diversity of ... before. , Only 8.5 percent to 16.2 percent ...
(Date:9/30/2014)... EVANSTON, Ill. --- Do we think of nature as something ... something we need to "preserve?" Or do we think of ... a part of nature, but what about a house? ... They are also reflected in our actions, our speech and ... partnership with the University of Washington, the American Indian Center ...
(Date:9/30/2014)... The National Institutes of Health (NIH) awarded Lawrence ... develop an electrode array system that will enable ... through unprecedented resolution and scale. , LLNL,s grant-funded ... President Obama,s BRAIN (Brain Research through Advancing ... to revolutionize our understanding of the human mind ...
Breaking Biology News(10 mins):Microbes in Central Park soil: If they can make it there, they can make it anywhere 2Microbes in Central Park soil: If they can make it there, they can make it anywhere 3The cultural side of science communication 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 3
... Cassava experts are reporting new outbreaks and the increased spread ... rapidly proliferating plant virus could cause a 50 percent drop ... of food and income for 300 million Africans. , ... agriculture experts have been looking to the otherwise resilient cassava ...
... United States suffer from epilepsies, a group of neurological ... brain which often produce debilitating seizures. Although anti-epileptic ... of patients, the remaining one-third do not respond to ... can experience harmful side effects. NIH funded researchers at ...
... Energy Joint Genome Institute (DOE JGI) is among the ... on their potential applications in the fields of bioenergy ... JGI is also focused on developing tools that more ... that it, as well as other genome centers, generates. ...
Cached Biology News:Scientists alarmed by rapid spread of Brown Streak Disease in cassava 2Scientists alarmed by rapid spread of Brown Streak Disease in cassava 3Scientists alarmed by rapid spread of Brown Streak Disease in cassava 4A new cost-effective genome assembly process 2A new cost-effective genome assembly process 3
... The DNA120 is a dedicated concentrator for ... precipitates of DNA/RNA. The integrated system combines ... pump. The compact design, automatic pump and ... run time; one for heater time), makes ...
... (For small quantities of solvents with DNA ... concentrator/centrifugal evaporator systems respond to specific applications ... and safe concentration of heat-labile samples. The ... different of cold traps and a wide ...
... The Jouan RC10 series of vacuum ... product protection features allied to rapid and ... modules can be combined with oil-free or ... traps and a wide selection of rotors ...
For relative and/or absolute quantification with standard accuracy requirements using MS or NMR instruments...
Biology Products: